Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R. Narayanan

Showing results (361-370 of 364) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 364 results.
Plos One|July 12, 2013
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patientsMohideen S Jawahar, Vaithilingam V Banurekha, Chinnampedu N Paramasivan, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continentsMark J Boaz, Peter Hayes, Tony Tarragona, et al.
The National Medical Journal of India|December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicineAnant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
The Indian Journal of Medical Research|April 9, 2013
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges aheadSurendra K Sharma, Alladi Mohan, L S Chauhan, et al.
Pageof 37

Showing results (361-370 of 364) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 364 results.
Plos One|July 12, 2013
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patientsMohideen S Jawahar, Vaithilingam V Banurekha, Chinnampedu N Paramasivan, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continentsMark J Boaz, Peter Hayes, Tony Tarragona, et al.
The National Medical Journal of India|December 3, 2022
Cancer care continuum at a tertiary care centre in India during the Covid-19 pandemic and nationwide lockdown: Healthcare delivery through telemedicineAnant Gokarn, Amit Joshi, Tabassum Wadasadawala, et al.
The Indian Journal of Medical Research|April 9, 2013
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges aheadSurendra K Sharma, Alladi Mohan, L S Chauhan, et al.
Pageof 37